Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques

Biochemical and Biophysical Research Communications
Moon Kyoo JangYong Bok Park

Abstract

Genes induced or suppressed by oxidized low-density lipoproteins (oxLDL) in human monocytic THP-1 cells were searched using the differential display reverse transcriptase polymerase chain reaction. One of the differentially expressed (up-regulated) cDNA fragments was found to contain sequences corresponding to monocyte chemotactic protein-3 (MCP-3). The stimulatory effect of the oxLDL on the expression of MCP-3 mRNA was both time- and dose-dependent. Treatment with GF109203X and genistein, inhibitors of protein kinase C and tyrosine kinase, respectively, had no effect on the induction of MCP-3 mRNA by oxLDL, while treatment with cycloheximide inhibited the induction. The induction was reproduced by the lipid components in oxLDL such as 9-HODE and 13-HODE, which are known to activate the peroxisome proliferator-activated receptor gamma (PPARgamma). Introduction of an endogenous PPARgamma ligand, 15d-PGJ2, in the culture of THP-1 cells resulted in the induction of MCP-3 gene expression. Furthermore, analyses of human atherosclerotic plaques revealed that the expressional pattern of MCP-3 in the regions of neointimal and necrotic core overlapped with that of PPARgamma. These results suggest that oxLDL delivers its signal for MCP-3...Continue Reading

References

May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S D CushingA M Fogelman
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M T QuinnD Steinberg
May 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J R HesslerG M Chisolm
Nov 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·G JürgensH P Dinges
May 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·K J Williams, I Tabas
Aug 1, 1994·Atherosclerosis·M S Penn, G M Chisolm
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·G M ChisolmP E DiCorleto
Jul 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H HughesJ R Guyton
Mar 15, 1994·Biochemical and Biophysical Research Communications·L MouL Chalifour
Dec 15, 1995·The Journal of Biological Chemistry·C CombadiereP M Murphy
Jan 1, 1996·Free Radical Biology & Medicine·J A Berliner, J W Heinecke
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·P TontonozB M Spiegelman
Aug 22, 1997·The Journal of Biological Chemistry·D Steinberg
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·I MaorM Aviram
Jul 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·M A RamosA Iguchi
Aug 7, 1998·Atherosclerosis·F MachP Libby

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.